Encyclopedia of AIDS

Editor/Author Hope, Thomas J., Richman, Douglas and Stevenson, Mario
Publication Year: 2018
Publisher: Springer Science+Business Media

Price: Core Collection Only
ISBN: 978-1-4939-7101-5
Category: Health & Medicine - Health
Image Count: 393
Book Status: Available
Table of Contents

For the first time, the world's experts in HIV-AIDS have come together to publish the Encyclopedia of AIDS. The work features thousands of entries, including medical, cultural, social, and pharmacological essays.

Share this

This book is found in the following Credo Collections:

Table of Contents

  • Preface
  • List of Topics
  • Editors and Contributors
  • A
  • Acetylation
  • Actin
  • AIDS-Related Primary Central Nervous System Lymphoma
  • Anal Cancer
  • Anatomic Compartments as a Barrier to HIV Cure
  • Antibody Response to HIV-2
  • Antiretroviral Drug Penetration into Lymphoid Tissue
  • Antiretroviral Drug Penetration into the CNS Compartment
  • Antiretroviral Medications, Adult Care, and Treatment
  • Antiretroviral Therapy and Drug Resistance in HIV-2 Infection
  • Antiretroviral Therapy for HIV-Infected Infants, Children, and Adolescents in Resource-Rich Settings
  • Antiretroviral Therapy: When to Start
  • Antiretroviral Treatment in Resource-Limited Settings
  • APOBEC3F/G and Vif: Action and Counteractions
  • Arp2/3
  • Attachment/Binding
  • Autophagy and HIV Infection
  • B
  • Bacterial Respiratory and Invasive Pneumococcal Infections and HIV
  • BAF (BANF1)
  • Behavioral Aspects of HIV Mother-to-Child Transmission
  • Behavioral Aspects of HIV Treatment as Prevention
  • Behavioral Interventions for Adherence
  • Behavioral Science Highlights of Evidence and Research
  • Blood and Blood Product Donors and Recipients in China, Epidemiology of HIV/AIDS
  • Budding
  • Burkitt and Burkitt-Like Lymphoma
  • C
  • Cardiovascular Complications
  • cART and Supportive Care for HIV-Associated Malignancies
  • Case Management for Linkage
  • Cell-Intrinsic Immunity
  • Cellular and Soluble Immune Activation Markers in HIV-Infected Subjects
  • Cellular Cofactors for HIV-1 Transcription
  • Cellular Cofactors of HIV as Drug Targets
  • Cellular Immune Response to HIV-2 Infection
  • Central Memory CD4 T Cells
  • Cervical Cancer and HIV
  • Chagas Disease and HIV
  • Children, Care and Treatment
  • Children, Epidemiology of HIV/AIDS
  • Chronic Immune Activation in HIV
  • Circumcision and AIDS
  • Clinical Ethics in HIV/AIDS Prevention, Care, and Research
  • Cofilin, Trafficking
  • Collagen Deposition and Fibrosis in the Lymphatic Tissues of HIV-1 Infected Individuals
  • Combination Approaches to HIV Prevention
  • Community Viral Load
  • Comorbidity: Opioids
  • Comorbidity: Progressive Multifocal Leukoencephalopathy
  • Conjunctival Carcinoma
  • Counteraction of SAMHD1 by Vpx
  • CRM1
  • Cryptococcosis and HIV
  • Cryptosporidiosis
  • CXCR4, Coreceptors
  • Cyclophilin A and HIV-1 Replication
  • Cystoisosporiasis
  • Cytomegalovirus Infection and HIV
  • D
  • DDX3, Cofactors, and RNA Export
  • Delayed Sexual Debut
  • Dendritic Cell Interactions with HIV-1 Envelope Glycoprotein: Implications for Preventing Transmission
  • Differential Diagnosis of HIV-Associated Neurocognitive Disorders
  • Diffuse Large B-Cell Lymphoma
  • E
  • Eastern Europe and Central Asia, Specific Characteristics of HIV/AIDS Epidemic
  • Elderly: Epidemiology of HIV/AIDS
  • Entry Inhibitors
  • Epidemic Kaposi Sarcoma, Pathogenesis and Presentation
  • Epidemiology of AIDS-Defining Malignancies
  • Epidemiology of HIV-2 Infection in West Africa
  • Epidemiology of Non-AIDS-Defining Malignancies
  • Epstein-Barr Virus (EBV)
  • F
  • Faith Based Interventions
  • Family Interventions
  • Female Condoms
  • Female, Male and Transgender Sex Workers, Epidemiology of HIV/AIDS
  • Fusion
  • G
  • Gamma Delta T Cells
  • Gay men and other Men who have sex with men (MSM), Epidemiology of HIV/AIDS Introduction
  • Global NeuroAIDS
  • H
  • HAND Adjunctive Therapies: Reversing Neuronal Injury
  • Harm Reduction for Injection Drug Users
  • Health Care Workers, Epidemiology of HIV/AIDS
  • Healthcare Workers, Shortage and Task Shifting of
  • Hepatitis C Virus Infection and HIV
  • Hepatocellular Carcinoma in HIV-Positive Patients
  • HIV “Auxiliary” Proteins
  • HIV and Sexual Violence
  • HIV and SIV, B-Cell Responses to
  • HIV and SIV, CD4 T-Cell Responses to
  • HIV and SIV, CD8 T Cell Responses to
  • HIV Antigen Processing and Presentation
  • HIV Cancers in Resource-Limited Regions
  • HIV Compartments and Viral Rebound During Treatment Interruption
  • HIV Coreceptor Tropism in Different Reservoirs
  • HIV Counseling and Testing, Prevention of HIV
  • HIV Infection, Immune-Based Interventions for
  • HIV Life Cycle: Overview
  • HIV Neurocognitive Diagnosis, Natural History, and Treatment
  • HIV Prevention and African Americans
  • HIV Prevention and Asians and Pacific Islanders
  • HIV Prevention and Hispanics
  • HIV Prevention and Labor Migration
  • HIV Prevention and Women
  • HIV Prevention Efforts Within Substance Use Disorder Treatment Settings
  • HIV Prevention for MSM
  • HIV Prevention for Serodiscordant Couples
  • HIV Prevention for Stimulant Using Men Who Have Sex with Men
  • HIV Prevention in Persons 50 and Older
  • HIV Prevention in the Correctional System
  • HIV Prevention in Transgender Persons
  • HIV Prevention in Youth
  • HIV Reservoirs in Lymph Nodes and Spleen
  • HIV Reservoirs in the Central Nervous System
  • HIV Reservoirs Within the Lungs
  • HIV Testing and Counseling
  • HIV Transmission in Female Commercial Sex Workers and Host Protective Factors
  • HIV-1 Assembly Cofactors
  • HIV-1 Maturation
  • HIV-1 Mutational Escape from Host Immunity
  • HIV-1 Pathogenesis in the Gut
  • HIV-1 Preexposure Prophylaxis
  • HIV-1 Prevention Using Live-Attenuated Vaccines
  • HIV-1 Rev Expression and Functions
  • HIV-1 Transmission Blocking Microbicides
  • HIV-1 Transmission: Influence of Bodily Secretions
  • HIV-1 Virion Structure
  • HIV-2 Diagnosis and Viral Load Measurements
  • HIV-2 Envelope: Structure, Diversity, and Evolution
  • HIV-2 Infection in Europe, Epidemiology of
  • HIV-2 Infection: The Role of Immune Activation in Pathogenesis
  • HIV-2 Neurological Manifestations
  • HIV-2 Transmission
  • HIV-2, Phylogeographic Insights into the Origins and Epidemic History
  • HIV-2: Lessons from the Dakar Cohort
  • HIV-Associated Cancers
  • HIV-Associated Immune Exhaustion
  • Hodgkin Lymphoma in Patients with HIV Infection
  • Host Genetics and Genomics
  • Housing as HIV Prevention
  • Human Papillomavirus (HPV)
  • I
  • Identification and Validation of HIV Cofactors
  • Identifying Opportunities to Block HIV-1 Transmission in the Female Genital Tract
  • Immune Activation and HIV Transmission
  • Immunogenetics of HIV-2 Infection
  • Immunological Responses to Antiretroviral Therapy
  • Immunology of Latent HIV Infection
  • Immunopathogenesis of HIV Coinfections
  • Inflammasome and HIV
  • Inflammatory Cytokines
  • Inhibition of HIV-1 Spread: Cell-Free Versus Cell-Cell
  • Initial Antiretroviral Regimens
  • Integrase Inhibitors
  • Integration
  • Integrin Alpha4beta7
  • Interactions Between HIV-2 and Host Restriction Factors
  • J
  • Jail and Prison Populations, Epidemiology of HIV/AIDS
  • K
  • Kaposi Sarcoma-Associated Herpesvirus (KSHV) or Human Herpesvirus 8 (HHV-8)
  • KIR Locus Variation
  • L
  • Latin America and the Caribbean: Specific Characteristics of the HIV/AIDS Epidemic
  • Leishmaniasis and HIV
  • Long-Acting Nanoformulated Antiretroviral Therapy
  • Long-Term Nonprogressors and Elite Controllers
  • Lung Cancer
  • Lymphocyte Apoptosis
  • M
  • M. avium Complex and Other Nontuberculous Mycobacteria and HIV
  • Macrophages in HIV Immunopathogenesis
  • Macrophage-Specific Aspects of HIV-1 Infection
  • Male Condoms
  • Malignancies in Children with HIV Infection
  • Management of AIDS-Related Kaposi's Sarcoma
  • Mass Media and HIV Prevention
  • Maturation Inhibitor
  • Medication Adherence and HIV-Associated Neurocognitive Disorders (HAND)
  • Merkel Cell Carcinoma and Other HIV-Associated Skin Cancers
  • Merkel Cell Polyomavirus (MCV)
  • MHC Locus Variation
  • Microbial Translocation
  • Microfinance/Microenterprise Approaches to HIV Prevention
  • Microsporidiosis
  • Molecular Biology of HIV-2
  • Mother-to-Child Transmission of HIV-1: Role of Receptor Usage and Target Cells
  • MTCT HIV-1 Transmission Update: Transmission Routes and Mechanisms
  • Mucosal Immunity to HIV-1
  • Mucosal Pathogenesis in SIV Infection
  • Multicentric Castleman Disease
  • Multilevel Interventions/Structural Approaches to HIV Prevention
  • MX2 and HIV-1 Restriction
  • N
  • Natural History and Clinical Features of HIV-2 Infection
  • Natural Killer Cells and Their Role in Preventing HIV-1 Transmission
  • Natural Killer Cells Function and Innate Immunity in HIV-2 Infection
  • Nef/Env/Vpu/Tetherin
  • Network Interventions
  • NeuroAIDS in Resource-Poor Settings, Assessment, and Treatment of
  • Neuro-AIDS, Immunopathogenesis of
  • Neurocognitive Functioning in HIV-infected Substance Users
  • Neurocognitive Outcomes in HIV-Infected Children and Adolescents
  • Neuroinflammation and HAND: Therapeutic Targeting
  • Neuropsychological Testing in HIV-Infected Individuals
  • Neurotoxic Consequences of Antiretroviral Therapies
  • NKT Cells: Bridging Innate and Adaptive Immunity
  • Nonhuman Primate Models of HIV Transmission
  • Non-injecting Drug Users, Epidemiology of HIV/AIDS
  • Non-neutralizing Antibody Responses and Protection Against HIV-1
  • Non-Nucleoside Reverse Transcriptase Inhibitors for Treatment of HIV Infection
  • Nonpathogenic SIV Infection of Sooty Mangabeys
  • NRTIs
  • Nuclear Import: HIV-1 Goes NUPs
  • Nurse-Delivered Interventions for Adherence
  • O
  • Origin and Distribution of HIV-1 Subtypes
  • Other HPV-Associated Cancers (Oropharyngeal and Penile)
  • Overcoming the Transcriptional Block: The HIV-1 Tat Auxiliary Protein
  • Overview of HIV CNS Infection
  • Overview: Immunopathogenesis
  • P
  • PD-1
  • Peer-Based Intervention Approaches
  • PIMT/TGS1
  • PKR and HIV Replication
  • Plasmablastic Lymphoma
  • Positive Health, Dignity, and Prevention (PHDP)
  • Post-treatment Controllers
  • Preexposure Prophylaxis (PrEP)
  • Pregnant Women: Care and Treatment
  • Presentation and Pathogenesis of B-Cell Lymphoid Cancers Associated with HIV Infection
  • Preventing HIV-1 Transmission Through Vaccine-Induced Immune Responses
  • Preventing Mother-to-Child Transmission (PMTCT): Prevention of HIV
  • Preventing Mother-to-Child Transmission of HIV-1
  • Prevention Clinical Trials: Highlights of Evidence and Research
  • Prevention Counseling and Other Strategies in the HIV Care Setting
  • Prevention for People Living with HIV
  • Prevention of Alcohol-Related HIV Risk Behavior
  • Prevention of Mother-to-Child Transmission of AIDS
  • Primary Effusion Lymphoma
  • Progressive Multifocal Leukoencephalopathy and HIV
  • Protease Inhibitor
  • Pyroptosis in HIV Infection: HIV Offense Meets a Fiery Host Defense
  • R
  • Recombinant Forms of HIV-2
  • Retention in Care Interventions
  • Reverse Transcriptase-Catalyzed HIV-1 DNA Synthesis
  • Risk of Sexual HIV-1 Transmission: Coinfections Associated with Risk
  • Role of Antibodies in HIV Transmission
  • Role of Dendritic Cells in HIV-2 Pathogenesis
  • Role of Histone Deacetylases 1 and Yin Yang 1 Protein in Proviral Latency
  • Role of LEDGF/p75 in Cell Biology and Disease Pathogenesis
  • Role of Regulatory T Cells During HIV Infection
  • Role of Transportin-SR2 (Transportin-3, TRN-SR2, TNPO3) in HIV Replication
  • S
  • Salmonellosis and Other Bacterial Enteric Infections and HIV
  • Sex Work and HIV Prevention
  • SIV Infection in Mandrills
  • SIV Infection of African Green Monkeys
  • SIVmac Infection of Macaques, Immunopathogenesis of
  • SLX4 Complex and HIV Replication
  • South, Southeast, and East Asia-Specific Characteristics of HIV/AIDS Epidemic
  • Stem Cell Transplantation
  • Surveillance Case Definition
  • Systems Biology
  • T
  • T Follicular Helper Cells in HIV Infection
  • T Memory Stem Cells
  • Talaromyces (Penicillium) marneffei and HIV
  • Tat Expression and Function
  • T-Cell Homeostasis
  • Th17 Cells
  • Thymic Function
  • Tim-3
  • Toxoplasmosis in HIV-Infected Patients
  • Transcription (Initiation, Regulation, Elongation)
  • Translational Interventions (Intervention Technology Transfer)
  • Transmission HIV-2: Origin, Epidemiology, and Phenotype
  • Treatment Failure and Resistance
  • Treatment of Histoplasmosis, Coccidioidomycosis, and Paracoccidioidomycosis in Patients with HIV Infection
  • TRIM Protein Family and Viral Restriction
  • TRIM5 Alpha and HIV-2 Infection
  • TRIM5alpha
  • Tropism and Properties of the HIV-1 Envelope Glycoprotein in Transmission
  • Tuberculosis and HIV
  • U
  • Uncoating and Nuclear Entry
  • Update on HIV-1 and HIV-2 Dual Infection
  • Use of Technology and Social Networking in HIV Prevention
  • V
  • Vaccine Efforts Against AIDS
  • Viral Fitness in Hosts
  • Viremic Nonprogressors
  • Virus Assembly
  • Virus-Host Evolution and Positive Selection
  • W
  • Women, Epidemiology of HIV/AIDS